Jenburkt Pharmaceuticals Limited was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family during the period 1986. The Company engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. It works more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation serve to government, semi-government institutions, missionary hospitals, public sector enterprises, etc.
The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.
In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.
Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year. FY 2026 saw genuine distinction while the Company launched Cartisafe Forte, India's first fixed-dose combination of Undenatured Type II Collagen (40 mg), Glucosa ...mine HCl (1500 mg), Chondroitin Sulphate (50 mg), and Hyaluronic Acid (30 mg). It launched Nervijen DP - a Pregabalin + Duloxetine combination available in Monthly Compliance Packs (50 mg and 75 mg variants) . Further, it launched Powergesic Natura Oil in association with KLE Ayurvedic Medical College, Belagavi. Additionally, Company launched Powergesic Gel 15 gm, Zixspas, Zixlam Forte, and Piritexyl LD during the year.
FAQs on Jenburkt Pharmaceuticals Ltd
1. Can I buy Jenburkt Pharmaceuticals Ltd from PL Capital? ›
Yes, you can invest in Jenburkt Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Jenburkt Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Jenburkt Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Jenburkt Pharmaceuticals Ltd pay dividends? ›
Yes, Jenburkt Pharmaceuticals Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Jenburkt Pharmaceuticals Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Jenburkt Pharmaceuticals Ltd ? ›
As of
10-Aug-2026 , 15:51:40 the share price for Jenburkt Pharmaceuticals Ltd. is ₹ 1062.55 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Jenburkt Pharmaceuticals Ltd ? ›
The 52-week high and low of Jenburkt Pharmaceuticals Ltd share price is ₹ 944 - ₹ 1321 as of
10-Aug-2026 , 15:51:40 .
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Jenburkt Pharmaceuticals Ltd
Invest systematically in stocks with the PL Capital app
